Global TravEpiNet: Global Travelers' Health Surveillance, Applications, and Cons
Project Number5U01CK000175-02
Former Number2U01CK000174-01
Contact PI/Project LeaderRYAN, EDWARD T. Other PIs
Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
International travel may not only increase the risk of infection for an individual traveler,
but may also contribute to the global spread of infections. A better understanding of this
epidemiologically important population could lead to improved interventions to promote the
health of international travelers, and to diminish the spread of infections within their home
communities. This renewal application focuses on Global TravEpiNet -- a consortium of clinics
providing pre-travel health advice. In TravEpiNet, data on travelers are collected via a novel
web-tool that simultaneously collects data, and aids health care practitioners in providing
essential recommendations. Since beginning data collection in 2009, information regarding
more than 11,000 U.S. international trips has been collected, and analyses focusing on subsets
of high-risk travelers, interventions, and cost-analyses are ongoing. We propose to build upon
this foundation in this renewal application. Specifically, we now propose four Specific Aims.
In Specific Aim #1, we propose to (a) maintain, improve, and update the Global TravEpiNet
web-tool, focusing on optimizing its ability to function as (i) an up-to-date interactive Yellow
Book practice guidance tool and (ii) data collection surveillance system that (iii) integrates
health care provider responses to assist practice guidance, (b) assess the impact of the
TravEpiNet web-tool and system to facilitate optimal practice, and (c) work with CDC to
maximize utility of comparisons of pre and post-travel surveillance data systems. In Specific
Aim #2, we propose to (a) collect and analyze data on global international travelers, including
travel demographics and preventative strategies, particularly focusing on high-risk travelers, and
(b) assess the risk of illness in international travelers through an interactive web-based survey
system. In Specific Aim #3, we propose to (a) maintain, improve and expand the Global
TravEpiNet Consortium, especially focusing on expanding membership of clinics providing care
to VFR travelers, high-risk travelers, students, and local health departments, and (b) expand
access to the TravEpiNet web-tool to guide optimal practice beyond consortium membership,
especially among primary care providers and non-expert practitioners. In Specific Aim #4, we
propose to develop new approaches to increase pre-travel health-care seeking behavior by
high-risk travelers, specifically, we propose to develop, test, deploy, and assess a traveler-
oriented web-tool to inform travelers of potential travel-related health risks, and to facilitate
interaction of international travelers with their health care providers.
Public Health Relevance Statement
PROJECT NARRATIVE
International travel may not only increase the risk of infection for an individual
traveler, but may also contribute to the global spread of infections. This renewal
application focuses on Global TravEpiNet -- a consortium of clinics providing pre-travel
health advice, and uses a novel web-tool that simultaneously collects data, and aids
health care practitioners in providing essential recommendations. We propose to build
upon the foundation provided by TravEpiNet to (1) maintain, enhance, expand access to,
and assess impact of the TravEpiNet web-tool and consortium, (2) develop and assess a
web-tool to assess risks of international travel, especially among high-risk travelers, (3)
develop and assses a traveler-oriented web-tool to minimize health risks associated with
international travel, and (4) analyze and communicate data to inform public health
recommendations for international travelers, particularly regarding high-risk travelers,
with the goal of preserving and advancing the health of the American public.
National Center for Emerging and Zoonotic Infectious Diseases
CFDA Code
283
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
30-September-2011
Project End Date
29-September-2016
Budget Start Date
30-September-2012
Budget End Date
29-September-2013
Project Funding Information for 2012
Total Funding
$755,000
Direct Costs
$437,410
Indirect Costs
$317,590
Year
Funding IC
FY Total Cost by IC
2012
National Center for Emerging and Zoonotic Infectious Diseases
$755,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01CK000175-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01CK000175-02
Patents
No Patents information available for 5U01CK000175-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01CK000175-02
Clinical Studies
No Clinical Studies information available for 5U01CK000175-02
News and More
Related News Releases
No news release information available for 5U01CK000175-02
History
No Historical information available for 5U01CK000175-02
Similar Projects
No Similar Projects information available for 5U01CK000175-02